Previous studies have indicated that elimination of parasitemia in Trypanosoma muscul infection is brought about by immunoglobulin G2a antibodies, C3, and an effector cell. Experiments were designed to identify the putative effector cell by using several approaches. Infected C5-deficient or C5-sufficient mice treated with silica particles or given 900 rads of radiation 3 days earlier effectively eliminated trypanosomes following adnministration of immune plasma (IP). Silica-treated, noninfected mice given T. musculi preincubated with IP also cleared the parasites. Radiolabeling studies revealed that uptake of the cleared trypanosomes by the liver in normal mice was relatively low (24%) and fell only slightly (19%) in silica-treated mice. In contrast, uptake of radiolabeled sheep erythrocytes by the liver was normally much higher (47%) and fell drastically (7%) in silica-treated mice. Mice were then immunocompromised by 900 rads of radiation, silica particles, and anti-platelet serum combined before IP-sensitized trypanosomes were given. Leukocyte and platelet counts were both reduced by 95% and sheep erythrocyte uptake by the liver fell from 77 to 5%; however, >99% of the inmjected trypanosomes were cleared in these mice and uptake of radiolabeled trypanosomes by the liver was similar to that of normal mice. Lastly, in anesthetized mice in which Kupffer cells were excluded surgically from the circulation, >99% of the IP-sensitized trypanosomes disappeared rapidly from the blood. Only 7% of the radiolabel was found in the liver versus 60% in sham-operated mice. The results are interpreted as showing that hepatic Kupffer cells play a minor role in the immune elimination of T. musculi. Likewise, radiosensitive leukocytes and platelets are unlikely to be sole candidates for the putative effector cell that mediates a cure of murine trypanosomiasis.
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Trypanosoma musculi is a natural parasite of mice. It produces a characteristic infection lasting for approximately 3 weeks and comprises an exponential growth phase, a plateau phase, and an elimination phase (10) . Recent studies in our laboratory have demonstrated that parasitemia can be eliminated in various strains of infected mice by passive transfer of immune plasma (IP) from cured mice (12, 15) and that this curative activity is associated with the immunoglobulin G2a fraction of IP (14, 15) . A requ.4rement for compo.-nent 3 of complement (C3) in the elimination process has also been demonstrated (13) . Mouse strains deficient in component 5 of complement (C5) are able to cure the natural infection (4, 15) , and passive transfer of C5-deficient IP into infected C5-deficient mice brings about elimination of parasites as effectively as in normocomplementemic strains (15) . In view of the absence of activated late-acting complement components to mediate trypanolysis in C5-deficient mouse strains, it is logical to conclude that antibody and C3 act in concert with an effector cell to destroy trypanosomes in this situation. This idea is supported by our recent observations that when T. musculi organisms are cultured in vitro with IP (with C3), the parasites are not destroyed when IP from C5-deficient animals is used (15) . In all likelihood, the putative effector cell is not present (or not present in sufficient numbers to be effective) in the culture system. It should be noted that in the presence of C5, the parasites are killed in this in vitro system (15). Thus, it appears that the major mechanism of trypanosome elimination, and indeed, from Jackson Laboratory. Retired female breeders were usually used for preparation of IP. Mice were infected intravenously (i.v.) with an inoculum of 104 T. musculi (Partinico II strain) organisms, and parasitemias were monitored as described previously (13) .
Plasma preparation. IP was obtained from C5-deficient B10.D2/oSn or A/J mice 28 days postinoculation (p.i.) approximately 1 week after clearance of infection (13) . Normal mouse plasma (NMP) was obtained from noninfected mice of the same strain. When required, plasma was heat treated by incubation at 56°C for 30 min (13 Anti-platelet serum. Rabbit anti-platelet serum was prepared by immunizing two rabbits intradermally each with 6 x 108 mouse platelets separated from whole blood, followed by a booster injection of 1.5 x 109 platelets 2 weeks later. After a further week, the rabbits were bled by cardiac puncture, the serum was collected, and small samples were absorbed three times with equal volumes of a mixture of washed mouse spleen, thymus, and liver cells. Mice received 0.2-ml doses of the absorbed antiserum intraperitoneally.
RESULTS
Effect of irradiation or silica treatment on elimination of trypanosomes following IP treatment. Groups of B10.D2/nSn and B10.D2/oSn strain mice were infected with 104 parasites and were irradiated (900 R) on day 10 p.i.; given three 3-mg doses of silica on days 10, 11, and 12 p.i.; or left untreated. On day 12 p.i., all of the mice received 0.4 ml of IP. Another group of untreated infected mice received heat-treated IP as a control, since heat treatment destroys the curative activity (12) . Parasitemia was measured before plasma administration on day 12 p.i. and 24 and 48 h after plasma administration.
In mice that received IP, the number of trypanosomes in the blood fell to undetectable levels, despite prior exposure to either irradiation or silica particles (Table 1) . Thus, mice immunodeprived by these methods retained the ability to eliminate T. musculi in the presence of IP.
To confirm the effectiveness of silica treatment in depressing mononuclear phagocyte function, another group of identically treated mice were tested for sensitivity to infection with Listeria monocytogenes by using methods described previously (8) . The number of bacteria measured in the liver 48 h after injection of the listerias was over log1o 3 times higher in the silica-treated group than in a nontreated control group, thus confirming the effect of silica treatment on mononuclear phagocyte function (data not shown).
Similar experiments were performed with C57BL/6 and DBA/2 strain mice and other regimens of silica treatment (up to 5-mg doses) with essentially the same findings, namely, that silica treatment does not impair clearance of T. musculi following IP treatment. It was also possible to irradiate mice for up to 5 It should be noted that B10.D2/oSn and DBAI2 strain mice are deficient in C5. Thus, even if complement-mediated lysis of T. musculi could account for the elimination of parasitemia following IP treatment in silica-treated and irradiated B10.D2/nSn and C57BL/6 mice, this mechanism is unable to account for the findings obtained with C5-deficient strains.
Determination of the best method to measure IP-mediated clearance of 75Se-labeled T. musculi in normal and silicatreated mice. Since trypanosomes are cleared from the blood even in immunodeprived mice, the next objective was to ascertain the fate of the cleared organisms in both normal and immunodeprived animals and, in particular, to examine the putative role of the liver in this event. Initially, the experiments were performed by introducing 75Se-labeled trypanosomes into naive mice (pretreated with silica) or normal animals shortly before giving IP or NMP and measuring the distribution of radiolabel in various organs after a suitable interval. In these experiments, the trypanosomes were always cleared from the blood by IP, even in immunodeprived hosts, but the method was laborious and the variation in the radiolabel values within a single group was rather high. Therefore, a different protocol was adopted in which 75Se-labeled trypanosomes were sensitized in vitro with IP and then injected into noninfected normal or immunodeprived mice and their fate was investigated. The results were essentially the same as those of the earlier experiments with preinfected mice, but the radiolabel values within each group were more consistent, so that this method was adopted for the subsequent experiments. Since trypanosomes presensitized with IP are eliminated while those incubated with NMP are not (see below), it seems reasonable to assume that the pathway of clearance of these presensitized trypanosomes in noninfected mice is likely to be the same as that which occurs when infected mice are treated with IP and the parasitemia is cleared (our previous protocol) or when the parasites are eliminated in the normal course of infection. Organ distribution of 75Se-labeled T. musculi pretreated with IP or NMP and injected into normal or silica-treated mice. Groups of B10.D2/oSn strain mice were given 5 mg of silica particles per mouse i.v. or left untreated. One day later, the mice each received approximately 106 trypanosomes that had been preincubated with either IP or NMP. As a comparison, other groups of mice were given the same number of 51Cr-labeled, sensitized SRBC. One hour later, the mice were bled under ether anesthesia through the retroorbital sinus and killed. Various organs were collected, and the radioactivity was measured. Parasitemias were enumerated in infected mice on wet smears prepared from the blood.
When normal mice were injected with trypanosomes that had been sensitized with IP, hepatic uptake of radiolabel was higher (24%) than in mice injected with trypanosomes preincubated with NMP (12%) (Fig. 1 ). This indicates that immune clearance of sensitized trypanosomes by the liver occurred to some extent. However, uptake of sensitized 51Cr-labeled, sensitized SRBC by the liver was, by comparison, much greater (47%; Fig. 2 ), suggesting that the liver plays a somewhat minor role in immune clearance of trypanosomes. Moreover, when Kupffer cell function was impaired by silica treatment, the uptake of IP-sensitized trypanosomes by the liver was not greatly affected (19 versus 24%; Fig. 1 ); in contrast, uptake of sensitized SRBC by the liver was almost eliminated under these conditions (7 versus 47%; Fig. 2 ). The percentage of radioactivity found remaining in the blood changed in the reverse direction, as expected.
When the mice were injected with trypanosomes sensitized with IP, no parasites were detected in the blood at the time of sacrifice (Table 2 ). In contrast, trypanosomes preincubated in NMP remained in the blood in large numbers. These differences were reflected in the greater amount of radioactivity remaining in the blood of mice given trypanosomes preincubated with NMP (46 to 50%) rather than IP (20 to 26%) (Fig. 1) .
To confirm and extend these observations, the same experiment was repeated with BlO.D2/oSn strain mice with a range of trypanosome inocula from 4 x 106 to 108 per mouse and was also done with a C5-sufficient mouse strain, C57BL/6 (but with incubation of the parasites in strain B10.D2oSn mouse IP to preclude the possibility of trypanolysis in vitro). The data obtained (Table 3) were comparable to the earlier findings; i.e., immune clearance of trypanosomes by the liver was modest (30 to 35% of the total radioactivity was taken up) and was only moderately reduced in silica-treated mice (17 to 22% uptake); however, the parasites were cleared from the circulation. Not surprisingly, the parasitemia was not completely cleared when the highest dose (108) of trypanosomes was given; however, it was markedly lower in mice that received IP-sensitized parasites than in the control group. In these experiments, radiolabel uptake was also measured in the spleen and found to be higher in silica-treated mice; this is in contrast to the reduced uptake by the livers of silica-treated mice. Values for the lungs and kidneys were also measured. They ranged from 1 to 5% and were of no particular interest (data not shown). Radiolabel uptake in the skin was not measured, although perhaps it should have been, in view of the substantial numbers of phagocytes in this organ. The clearance of radiolabeled, sensitized SRBC from blood and their uptake by organs were measured in the normal and silica-treated groups of mice used in each of the above-described experiments. The data (Table 4) confirmed that clearance of foreign cells by Kupffer cells was virtually eliminated in silica-treated mice, and this was true even when the injected inoculum was small.
Clearance and distribution in organs of 75Se-labeled, sensitized T. musculi in mice treated with silica, irradiation, and anti-platelet serum. An experiment was performed in which combined treatments were used to deplete mice of leukocytes, Kupffer cells, and platelets. Thus, B1O.D2/oSn mice were irradiated with 900 rads of radiation on day -6 and given 5 mg of silica particles on day -1 and two doses of 0.2 ml each of anti-platelet serum, on days -1 and 0, respectively. The normal control groups were either nontreated mice or mice treated as described above and given, in addition, two doses of 0.2 ml of CVF on days -1 and 0. All mice received 6.6 x 107 75Se-labeled trypanosomes preincubated with IP on day 0. The percentages of radiolabel in various organs were measured 1 h after injection of the trypanosomes, and parasitemia was estimated. To assess the immune status of the immunocomprised mice, leukocyte and platelet counts were measured before injection of the parasites and afterward, at the time of sacrifice. In addition, the uptake of radiolabeled, opsonized SRBC by the liver was measured as before in other normal and immunocompromised groups of mice for comparison.
No detectable trypanosomes remained in the blood of normal mice. In immunocompromised mice also, most (>99%) of the trypanosomes disappeared from the circulation. The number of T. musculi organisms injected was log1o 6.6 per mouse, of which log1o 2.8 + 1.4 remained. In mice that had received CVF, almost all of the trypanosomes, namely, log1o 6 .04 + 0.05, remained in the blood. This was to be expected since, as shown previously, clearance of T. musculi by i.v. injection of IP fails to occur if the mice have been pretreated with CVF (13). These mice thus provided an excellent negative control group in the present experiments.
Assessment of the immune status of the mice is shown in Fig. 3 . In immunocomprised mice, the leukocyte and platelet counts were reduced by 95% and the ability of the liver to take up SRBC was largely destroyed. Differential counts of leukocytes were not done at the time but were performed later in a separate experiment with mice given an identical treatment regimen. In normal and immunocompromised mice, respectively, the values (105) for polymorphonuclear accumulation of radiolabel in the liver was relatively low (29%) compared with that seen for SRBC uptake (77%; Fig.  3 ). Furthermore, since CVF treatment prevents trypanosome clearance, it can be assumed that the uptake value for the liver obtained with this group (18%; Fig. 4 ) represents the amount of radiolabel that would be found in the liver when there is no specific uptake of trypanosomes. Thus, in Fig. 4 . Leukocyte and platelet counts were measured before injection of T. musculi (before T.m.) and 1 h later, at the time of sacrifice (after T.m.). Hepatic uptake of 51Cr-labeled SRBC was measured in other groups of mice. The total radioactivity injected into each mouse was 44,310 cpm. Each value represents the mean of three or four mice + 1 standard error of the mean.
liver had been occluded (Fig. 5) . The radiolabeling data (Fig.  6) confirmed that very few parasites reached the liver in the experimental groups, the value being 7% for mice receiving IP-treated trypanosomes compared with 60% of the radiolabel found in the sham-operated group. The distribution of radiolabel among organs in this experiment was somewhat different from that seen in the previous experiments, possibly because the animals were under anesthesia and/or because the values were taken 15 min rather than 1 h after injection of the parasites. In particular, it is interesting that there was substantial accumulation of radiolabel in the lungs of experimental mice that received IP-treated trypanosomes. As expected, uptake of radiolabeled, NMP-treated trypanosomes was lower and of no particular interest (data not shown).
DISCUSSION
The experiments described in this report were done to identify the effector cell which is inferred to mediate immune destruction of T. musculi. For this reason, the experiments were always done with C5-deficient mouse strains ( (Fig. 6 ) provided direct evidence that Kupffer cells had been excluded from the circulation and therefore could not have been responsible for removal of the trypanosomes that disappeared from the blood (Fig. 5) .
Since in other models of trypanosome infections in mice, the liver was found to be the principal site of phagocytic uptake of radiolabeled parasites (1, 3, 5) , the experiments were directed primarily at examining the role of the fixed liver macrophages in T. musculi infection. The data showed that the liver specifically takes up a certain proportion of the radiolabeled, sensitized trypanosomes. Thus, the results of all of the experiments (except the last one in which the mice Jptake of She-labeled trypanosomes by various organs normal mice and CVF-treated control mice, uptake by the xperiacent shown in Fig. 5 . The total radioactivity liver was 11% higher in the normal group (Fig. 4) . This value each mouse was 6,821mis probably a fair representation of the amount of radiolabeled parasites taken up specifically by the liver. In experiments reported by others who used T. brucei (3, 5) or T. on of the trypanosomes. In these studies, it was rhodesiense (1), antibody-mediated hepatic uptake of radiole to measure the immune clearance of trypanolabeled trypanosomes was 50 to 60% or more; also, as icubated with IP in noninfected mice. As outlined mentioned above, in the present studies, hepatic uptake of we believe that the mechanism of clearance in sensitized SRBC was 43 to 83%. The liver does not appear to tas essentially the same as that responsible for be a major site of T. musculi clearance, therefore, when out a cure of the normal infection.
hepatic uptake of this trypanosome in our experiments is point to emphasize is that in every experiment, compared with that observed for other trypanosomes or nethod of deprivation was used, the immune other opsonized foreign particles, such as SRBC. Furthermechanism remained essentially intact and the more, hepatic uptake of radiolabeled, sensitized T. musculi ies were removed from the circulation (except was only moderately reduced in silica-treated mice; i.e., the y large inoculum was given). This could mean that range was 17 to 22% in these mice compared with 24 to 35% ie cell populations affected by the deprivation in normal mice. In contrast, SRBC uptake was drastically is involved in the clearance process. Another reduced in silica-treated mice (i.e., 2 to 6% from 43 to 83%). could be that more than one cell type is able to Lastly, when the hepatic circulation was interrupted, the une elimination so that in the absence of one percentage of radiolabel found in the liver was very low (7%) (e.g., Kupffer cells), another cell population (Fig. 6 
